Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy

MLA

Carmen Bellas, et al. Epstein-Barr Virus-Latent Membrane Protein 1 Expression Has a Favorable Influence in the Outcome of Patients with Hodgkin’s Disease Treated with Chemotherapy. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....683833e3c6647052de599ace92e7391c&authtype=sso&custid=ns315887. Accessed 23 Jan. 2025.

APA

Carmen Bellas, Kaimundo García Del Moral, Javier Menárguez, Máximo Fraga, Carlos Montalbán, Manuel M. Morente, Víctor Abraira, Margarita Sánchez-Beato, Horacio Olivaj, Beatriz Aguilera, Agustian Acevedo, & Miguel A. Piris. (n.d.). Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin’s disease treated with chemotherapy.

Chicago

Carmen Bellas, Kaimundo García Del Moral, Javier Menárguez, Máximo Fraga, Carlos Montalbán, Manuel M. Morente, Víctor Abraira, et al. 2025. “Epstein-Barr Virus-Latent Membrane Protein 1 Expression Has a Favorable Influence in the Outcome of Patients with Hodgkin’s Disease Treated with Chemotherapy.” Accessed January 23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....683833e3c6647052de599ace92e7391c&authtype=sso&custid=ns315887.